Pfizer in-licenses Protalix's taliglucerase

Protalix Biotherapeutics Inc. (NYSE-A:PLX) granted Pfizer Inc. (NYSE:PFE) exclusive, worldwide rights, excluding Israel, to develop and commercialize taliglucerase alfa. Protalix plans to complete sub...